1-20 of 23
Ana Garrido
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Comparative Analysis of NGS and Digital PCR for Measurable Residual Disease Monitoring in Intensively Treated Acute Myeloid Leukemia Patients

Guillermo Ramil López, Alícia Artigas Baleri, Anna Giné Vilalta, Guadalupe Onate, Helena Castellet, Marina Díaz-Beyá, Mar Tormo, Marta Cervera, Rosa Coll, Jorge Jose Martinez Serra, Susana Vives, Antonio Garcia, Martin Mascaro Riera, Sara García, Ferran Vall-Llovera Calmet, Montserrat Arnan, Olga Salamero, Ana Garrido Diaz, Jordi Esteve Reyner, Josep F Nomdedeu Guinot, Jorge Sierra, Marta Pratcorona
Journal: Blood
Blood (2024) 144 (Supplement 1): 6167.
https://doi.org/10.1182/blood-2024-203130
Published: 2024
Journal Articles

Prognostic Value of the Measurable Residual Disease (MRD) in AML Treatment with Venetoclax in Combination with Hypomethylating Agents: Validation of the ELN 2021 MRD Recommendations

Carlos Jimenez-Vicente, Aina Cardus, Guillermo Ramil López, Guadalupe Onate, Iago Arribas, Sara Garcia-Avila, Lucia Gomez-Perez, Daniel Esteban, Antonella Sturla, Francesca Guijarro, Mònica López-Guerra, Sandra Castaño-Díez, Alexandra Martínez-Roca, Albert Cortés-Bullich, Amanda Isabel Perez, Ines Zugasti, Inés Monge-Escartin, Jorge Sierra, Susana Vives, Helena Pomares, Montserrat Arnan, Josep Nomdedeu, Ana Garrido, Marta Pratcorona, Marina Díaz-Beyá, Jordi Esteve
Journal: Blood
Blood (2024) 144 (Supplement 1): 225.
https://doi.org/10.1182/blood-2024-204503
Published: 2024
Journal Articles

Phase 1b Study of Menin-KMT2A Inhibitor Bleximenib in Combination with Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia with KMT2Ar or NPM1 Alterations

Christian Recher, Jenny O'Nions, Ibrahim Aldoss, Ana Alfonso Pierola, Alicia Allred, Juan Manuel Alonso-Dominguez, Laura Barreyro, Pierre Bories, Martin Curtis, Nikki Daskalakis, Matteo Giovanni Della Porta, Hartmut Döhner, Amber D'Souza, James P. Dugan, Jordi Esteve Reyner, Matthew Exum, Amir T. Fathi, Pasquale L. Fedele, Lucille Ferrante, Stan Gaj, Sylvain Garciaz, Ana Garrido, Sara Garrido Paniagua, Christina Guttke, Emmanuel Gyan, Brett Hiebert, Elias Jabbour, Madlen Jentzsch, Hagop M. Kantarjian, Marina Konopleva, Jan Krönke, Min Chul Kwon, Christina Loefgren, Oliver Lomas, Valentina Mancini, Ioannis Mantzaris, Giovanni Martinelli, Daniel Morillo Giles, Joseph Murphy, Kathryn Packman, Cristina Papayannidis, Ulrike Philippar, Uwe Platzbecker, Sravanti Rangaraju, Christoph Röllig, Olga Salamero, Madhu Sanga, Tim Sauer, Emma Searle, Natalia Tovar, Trevor Tucker, Nicolas Vallet, Lachlin Vaughan, Gala Vega, Paresh Vyas, Andrew Wei
Journal: Blood
Blood (2024) 144 (Supplement 1): 215.
https://doi.org/10.1182/blood-2024-207072
Published: 2024
Journal Articles

Ubtf tandem Duplications Define a Novel Subtype of Acute Myeloid Leukemia Associated with Younger Age, WT1 Mutations and HOXA9 Marked Overexpression

Helena Castellet, Guillermo Ramil López, Ana Garrido, Alícia Artigas-Baleri, Marta Pratcorona, Olga Salamero, Albert Cortés-Bullich, Susana Vives, Mar Tormo, Martin Mascaro Riera, David Gallardo, Josep Maria Marti Tutusaus, Antonio Garcia, Jorge Sierra, Jordi Esteve, Josep Nomdedeu
Journal: Blood
Blood (2023) 142 (Supplement 1): 6045.
https://doi.org/10.1182/blood-2023-186064
Published: 2023
Journal Articles

RAS Mutations in Adult Acute Myeloid Leukemia (AML). Frequency, Mutational Spectrum, and Identification of a Comutation Bias for KRAS K117 ( TET2 / ASXL1 )

Alícia Artigas-Baleri, Helena Castellet, Marta Pratcorona, Lurdes Zamora, Monica Lopez-Guerra, Bárbara Tazón, Susana Vives, Mar Tormo, Montserrat Arnan, Antoni Garcia-Guiñon, Rosa Coll., Antonia Sampol, Joan Bargay, Ferran Vall-Llovera, Olga Salamero, Felix Lopez-Cadenas, Ana Garrido Díaz, Jordi Esteve, Jorge Sierra, Josep F Nomdedeu
Journal: Blood
Blood (2022) 140 (Supplement 1): 11821–11823.
https://doi.org/10.1182/blood-2022-164718
Published: 2022
Journal Articles

Prospective Population-Based Analysis of Characteristics and Therapy Options in AML: The Case of Catalonia (PERIS Project)

Montserrat Hoyos, Ana Garrido, Montserrat Arnan, MD, Marina Diaz-Beyá, MD, Olga Salamero, MD, Susana Vives, MD, Antonio Garcia-Guiñon, MD, David Gallardo, MD, Marta Cervera, MD, Ferran Vall-Llovera, MD, Cristina Motlló, Brayan Merchan, MD, Imma Roig Martinez, Xavier Ortin, Pável E Olivera, MD, Anna Sureda Balari, MD PhD, David Valcarcel, Josep-Maria Ribera, Jordi Esteve, Jorge Sierra, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 32–33.
https://doi.org/10.1182/blood-2020-139160
Published: 2020
Journal Articles

Validation of the European Leukemianet 2017 Prognostic Classification for Patients with De Novo Acute Myeloid Leukemia Treated with a Risk-Adapted Protocol (CETLAM 2012)

Alex Bataller, MD, Ana Garrido, MD, Francesca Guijarro, MD, Marina Diaz-Beyá, MD, Guadalupe Oñate, MD, Montserrat Hoyos, Montserrat Arnan, MD, Mar Tormo, MD, Susana Vives, MD, Maria Paz Queipo De Llano, MD, Olga Salamero, MD, Rosa Coll, MD, David Gallardo, MD, Ferran Vall-Llovera, MD, Lourdes Escoda, MD, Antonia Sampol, MD, Antonio Garcia-Guiñon, MD, Brayan Merchan, MD, Joan Bargay, MD, Monica Lopez-Guerra, PhD, Marta Pratcorona, MD, Lurdes Zamora, PhD, Salut Brunet, MD, Josep F Nomdedeu, MD, Jorge Sierra, MD, Jordi Esteve
Journal: Blood
Blood (2020) 136 (Supplement 1): 31–32.
https://doi.org/10.1182/blood-2020-140670
Published: 2020
Journal Articles

Acute Myeloid Leukemia with Isocitrate Dehydrogenases (IDH) 1 and 2 Mutations. a Real-World Study from the European IDH Research Group

Giulia Maggioni, MD, Cristina Astrid Tentori, MD, Maria Teresa Voso, MD, Sonja Heibl, MD, Klaus H. Metzeler, MD, Jan Moritz Middeke, MD, Joana Desterro, Maria Carmo-Fonseca, Erica Travaglino, Paola Fazi, MD, Alfonso Piciocchi, MS, Annika Maria Dufour, PhD, Jordi Esteve, Marta Pratcorona, MD, Valentina Mancini, MD, Federico Lussana, MD, Karsten Spiekermann, Christian Thiede, MD, Friedrich Stolzel, MD, Aida Botelho de Sousa, Mar Tormo, Pamela Acha, Montserrat Arnan, Nicola Fracchiolla, MD, Marcus Hentrich, Christoph Sippel, Bernhard Heilmeier, Marcos Lemos, Albertina Nunes, Sonia Matos, Marina Diaz, Ana Garrido, MD, David Gallardo, MD, Susana Vives, MD, Olga Salamero, Elisabetta Todisco, MDPhD, Claudia Basilico, MD, Francesco Passamonti, Sigrid Machherndl-Spandl, MD, Lisa Pleyer, Jorge Sierra, Francesc Solé, PhD, Matteo Giovanni Della Porta, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 30–31.
https://doi.org/10.1182/blood-2020-140494
Published: 2020
Journal Articles

Risk-Adapted Intensive Chemotherapy for Primary ACUTE Myeloid Leukemia during the Last 25 YEARS: Increase in Complete Remission RATE, Hematopoietic Cell Transplantation Access and Decrease in Relapse Incidence Have LED to Improved Survival

Ana Garrido, Montserrat Hoyos, Marina Diaz-Beyá, MD, Montserrat Arnan, MD, Susana Vives, MD, Marisa Calabuig, MD, Olga Salamero, MD, David Gallardo, MD, Maria Paz Queipo De Llano, MD, Lourdes Escoda, MD, Antonia Sampol, MD, Ferran Vall-Llovera, MD, Antonio Garcia-Guiñon, MD, Merchan Brayan, MD, Joan Bargay, MD, J Pio Torres, Xavier Ortin, M Luz Amigo, Jose Maria Moraleda, MD PhD, José F. Falantes, David Valcarcel, Mar Tormo, MD, Josep-Maria Ribera, Salut Brunet, MD, Anna Sureda Balari, MD PhD, Jordi Esteve, Jorge Sierra, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 13–14.
https://doi.org/10.1182/blood-2020-140680
Published: 2020
Journal Articles

A Predictive Model for Early Death after Frontline Hypomethylating Agents in Elderly Unfit Acute Myeloid Leukemia Patients: Results from the Pethema Group

Fernando Ramos, David Martinez-Cuadron, Josefina Serrano, Maria Lopez-Pavia, Marta Fuertes-Nuñez, Teresa Bernal, Juan Ignacio Rodriguez-Gutierrez, Isabel Recio, Ana Garrido, Daniel Garcia, Claudia Lucia Sossa, MD, Cristina Gil, Rosario Varela, Pilar Martinez-Sanchez, Maria Angeles Foncillas, Mar Tormo, Antonia Cladera, Graca Esteves, José F. Falantes, Adolfo de la Fuente, Blanca Boluda, Miguel A. Sanz, Pau Montesinos Fernandez, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 648.
https://doi.org/10.1182/blood-2019-125053
Published: 2019
Journal Articles

Final Results of the AML12 Trial of the Spanish Cetlam Group in Adults with Acute Myeloid Leukemia (AML) up to the Age of 70 Years: Risk Adapted Post-Remission Allocation Based on Genetic Data and Minimal Residual Disease

Jorge Sierra, MD, Ana Garrido, Marina Diaz Beya, MD, Montserrat Hoyos, Marisa Calabuig, MD, Susana Vives, MD, Montserrat Arnan Sangerman, MD PhD, Maria Paz Queipo De Llano, MD, Olga Salamero, MD, Ferran Vall-Llovera, MD, Alex Bataller, Francisca Guijarro, MD, Lourdes Escoda, MD, Antonio Garcia-Guiñon, MD, Brayan Merchan, MD MSc, Xavier Ortin, Isabel Sanchez Ortega, MD PhD, Marta Pratcorona, MD PhD, Joan Bargay, MD PhD, Antonia Sampol, Josep Nomdedeu, MD PhD, David Gallardo, Josep-Maria Ribera, MD PhD, Mar Tormo, Jordi Esteve, Salut Brunet, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 289.
https://doi.org/10.1182/blood-2019-128682
Published: 2019
Journal Articles

Favorable Outcome in Patients with Acute Myeloblastic Leukemia (AML) with NPM1 Mutation Who Present an Inadequate Clearance or Relapse of Minimal/Measurable Residual Disease (MRD): Results of a Preemptive Intervention Policy (CETLAM-2012 Protocol)

Alex Bataller Torralba, MD, Marina Diaz-Beyá, MD, Ana Garrido, MD, Susana Vives, MD, Mar Tormo, MD PhD, Montserrat Arnan Sangerman, MD, Olga Salamero, MD, Antonia Sampol, MD PhD, Rosa Coll, MD, Monica Lopez-Guerra, PhD, Marta Pratcorona, MD PhD, Lurdes Zamora, PhD, Eva Villamón, PhD, Gael Roue, PhD, Adoración Blanco, PhD, Aina Oliver-Caldes, MD, Josep F Nomdedeu, MD, Dolors Colomer, PhD, Salut Brunet, MD PhD, Jorge Sierra, MD, Jordi Esteve, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1385.
https://doi.org/10.1182/blood-2018-99-110895
Published: 2018
Journal Articles

Prognostic Impact of the Interaction between DNMT3A mutation and Internal Tandem Duplication of the FLT3 Gene (FLT3-ITD) in Patients with D e Novo Mutated NPM1 (NPM1mut) a cute Myeloid Leukemia

Guadalupe Oñate, MD, Ana Garrido, MD, Jordi Esteve, MD PhD, Rosa Coll, MD, Montserrat Arnan Sangerman, MD, Susana Vives, MD, Antonia Sampol, MD PhD, Mar Tormo, MD PhD, Lourdes Escoda, MD, Maria Paz Queipo De Llano, MD, Antoni Garcia-Guiñon, MD, Joan Bargay, MD PhD, Olga Salamero, MD, Alba Aljarilla, Salut Brunet, MD PhD, Jorge Sierra, MD, Josep Nomdedeu, MD PhD, Marta Pratcorona, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1492.
https://doi.org/10.1182/blood-2018-99-115337
Published: 2018
Journal Articles

Therapy for Acute Myeloid Leukemia (AML) Adjusted to Genetic Data and Minimal Residual Disease: Results of the AML12 Trial of the Spanish Cetlam Group in Adults up to the Age of 70 Years

Jorge Sierra, Ana Garrido, MD, Susana Vives, MD, Maria Paz Queipo De Llano, Ramon Guàrdia, MD, Marina Diaz-Beyá, Marisa Calabuig, MD, Marta Pratcorona, Montserrat Arnan Sangerman, Olga Salamero, Marta Cervera, MD, Antonia Sampol, MD, Antoni Garcia-Guiñon, Carme Pedro, Josep M Marti, Joan Bargay, MD PhD, Llorenç Font, Josep F Nomdedeu, Montserrat Hoyos, Lourdes Escoda, Montserrat Batlle, Bryan Merchan, Isabel Sanchez-Ortega, Physician, Mar Tormo, MD PhD, David Gallardo, Josep-Maria Ribera, MD, Jordi Esteve, MD, Salut Brunet, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 567.
https://doi.org/10.1182/blood.V130.Suppl_1.567.567
Published: 2017
Journal Articles

Favorable Outcome of Older Patients with AML and a Favorable Genotype NPM1mut FLT3-ITD Treated with Intensive Chemotherapy: A Subgroup Analysis of Cetlam Protocol 2003 & 2012

Marta Pratcorona, Jordi Lopez-Pardo, MD, Ana Garrido, MD, Salut Brunet, MD PhD, Josep-Maria Ribera, MD PhD, Mar Tormo, MD PhD, Lourdes Escoda, MD PhD, Olga Salamero, Montserrat Arnan, MD PhD, David Gallardo, MD, Joan Bargay, MD, Montserrat Hoyos, PhD, Marina Diaz-Beya, MD PhD, Ruth M Risueño, Josep F. Nomdedeu, MD PhD, Jorge Sierra, MD PhD, Jordi Esteve, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2511.
https://doi.org/10.1182/blood.V126.23.2511.2511
Published: 2015
Journal Articles

Prognostic Impact of MLL Partial Tandem Duplication in Acute Myeloid Leukemia of Intermediate Cytogenetic Risk: A Subgroup Analysis of Cetlam Protocol 2003 & 2012

Marta Pratcorona, Ana Garrido, MD, Salut Brunet, MD PhD, Jordi Esteve, MD PhD, María Camino Estivill, PhD, M. Paz Queipo De Llano, MD, Susana Vives, Montserrat Arnan, MD PhD, David Gallardo, MD, Mar Tormo, MD PhD, Antoni Garcia-Guiñon, MD, Antonia Sampol, MD PhD, Olga Salamero, Josep Ma Martí, MD, Joan Bargay, MD PhD, M Carmen Pedro, MD, Montserrat Hoyos, PhD, Marina Diaz-Beya, MD PhD, Lourdes Escoda, MD PhD, Ramon Guàrdia, MD PhD, Josep Ribera, MD PhD, Jorge Sierra, MD PhD, Josep F. Nomdedeu, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2514.
https://doi.org/10.1182/blood.V126.23.2514.2514
Published: 2015
Journal Articles

Azacitidine in Older Patients with Acute Myeloid Leukemia (AML) and Adverse Karyotype. Subanalisis from the Alma Study

Jose Falantes, MD, Guillermo Deben, MD, Violeta Martinez Robles, Joan Bargay, MD, Olga Salamero, MD, Carmen Pedro, MD, Santiago Redondo, Ana Garrido, MD, Juan Miguel Bergua, Mar Tormo, MD, Blanca Xicoy, MD PhD, Patricia Font, Tomás José González-López, MDPhD, Fernando Ramos, MDPhDMPH
Journal: Blood
Blood (2014) 124 (21): 945.
https://doi.org/10.1182/blood.V124.21.945.945
Published: 2014
Journal Articles

Bone Marrow WT1 Levels In Long-Term Survivors Of Core-Binding Factor AML and Acute Promyelocytic Leukemia

Josep F Nomdedeu, MD, Montserrat Hoyos, Maite Carricondo, Elena Bussaglia, PhD, Maria-Concepcion Garcia-Dabrio, MD, Isabel Badell, MD, Camino Estivill, Ana Garrido, MD, Clara Martinez, MD, Salut Brunet, Anna Aventin, MD, Jorge Sierra, MD
Journal: Blood
Blood (2013) 122 (21): 4946.
https://doi.org/10.1182/blood.V122.21.4946.4946
Published: 2013
Journal Articles

The Impact Of European Leukemia Net (ELN) Genetic Classification On The Outcome Of Allogeneic Stem Cell Transplantation (ALLOHCT) For Acute Myeloid Leukemia (AML) In First Complete Remission

Jorge Sierra, PhD, MD, Ana Garrido, MD, Mar Tormo, MD, Ramon Guardia, MD, Josep F Nomdedeu, MD, Jordi Esteve, MD, PhD, Josep-Maria Ribera, MD, PhD, Rafael F. Duarte, MD, PhD, M. Paz Queipo De Llano, MD, Olga Salamero, MD, Carmen Pedro, MD, Joan Bargay, MD, Juan Besalduch, MD, PhD, Andreu Llorente, MD, Montserrat Hoyos, Montserrat Arnan, MD, Marta Pratcorona, MD, Susana Vives, MD, Marisa Calabuig, MD, David Gallardo, MD, PhD, Salut Brunet, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 2107.
https://doi.org/10.1182/blood.V122.21.2107.2107
Published: 2013
Journal Articles

Prognostic Impact of the Levels of Expression of Cell Surface Proteins Commonly Expressed by Blasts and Hematopoietic Precursor Cells in De Novo AML Patients: A Report From the Spanish Cetlam Study Group

Maria Concepcion Garcia-Dabrio, Montserrat Hoyos, Ana Garrido, Salut Brunet, Rafael F Duarte, MD, PhD, Josep-Maria Ribera, MD, PhD, Jordi Esteve, MD, PhD, Andreu Llorente, Mar Tormo, Ramon Guardia, Natalia Lloveras, Antoni Garcia, Inmaculada Heras, Juan Besalduch, M. Paz Queipo De Llano, MD, Javier Bueno, Joan Bargay, Pio Torres, Josep M. Marti-Tutusaus, Llorenç Font, Anna Aventin, MD, Quentin Lecrevisse, Alberto Orfao, Jorge Sierra, MD, PhD, Josep F. Nomdedeu, MD
Journal: Blood
Blood (2012) 120 (21): 1452.
https://doi.org/10.1182/blood.V120.21.1452.1452
Published: 2012